WDNAWisdomTree BioRevolution Fund

Grow my money5y track recordRanked #2,279 of 2,960 in this goal

Seeks to track the price and yield performance of the WisdomTree BioRevolution Index.

By WisdomTree · Launched 2021

Annual Cost

0.45%

#2,223 of 5,562 · average

Fund Size

$2M

#5,291 of 5,562 · small

Return (1Y)Goal

+48.8%

Track Record

5 years

#2,387 of 5,562 · seasoned

Performance

Total-return NAV · USD

Growth of $10,000

$14,686+46.9%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

Global

Strategy

Index tracking

Sector

Health care

Focus

Biotech & Genomics

Index tracked

WisdomTree BioRevolution Index

What it actually holds

By weight

Concentration

Top 10 holdings = 31.0% of fund✓ well diversified

DREY INST PREF GOV MM-MDSVXX

6.9%

Structure Therapeutics Inc

3.2%

Eli Lilly & Co

3.1%

Natera Inc

2.9%

Johnson & Johnson

2.7%

Moderna Inc

2.7%

Stoke Therapeutics Inc

2.5%

Pfizer Inc

2.4%

United Therapeutics Corp

2.3%

REGENXBIO Inc

2.3%

Asset allocation

Stocks

100.0%

By sector

Healthcare

88.1%

Basic Materials

7.3%

Consumer Defensive

4.7%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

25.9%High

Year-on-year price swings

Max drawdown

-58.9%Severe

Worst peak-to-trough loss

Sharpe (3Y)

0.12Below average

Sortino (3Y)

0.17Moderate downside risk

Where to buy

Listing

Exchange: Cboe BZX

Full fund details

Objective: Seeks to track the price and yield performance of the WisdomTree BioRevolution Index.
Strategy: Employs a passive management approach designed to track the WisdomTree BioRevolution Index using representative sampling. Invests in equity securities of companies transformed by advancements in genetics and biotechnology, with a focus on the Health Care Sector.
Inception date: June 1, 2021
Fund family: WisdomTree